Gestational trophoblastic disease describes a group of rare pregnancy related disorders that
span a spectrum of premalignant and malignant conditions. Hydatidiform mole (also termed …

Gestational trophoblastic diseases are a group of pregnancy-related disorders, originated
from trophoblast cells. They include benign and aggressive tumors, such as the invasive …

Background Patients with gestational trophoblastic neoplasia who have an International
Federation of Gynaecology and Obstetrics (FIGO) risk score of 5 or 6 usually receive non …

Background Synergistic antitumor effects of immunotherapy and chemotherapy have been
demonstrated in several solid tumors. However, this combination strategy has not been …

High-risk gestational trophoblastic neoplasia (GTN) has an increased risk of developing
chemoresistance to single-agent chemotherapy; therefore, the primary treatment should be …

Introduction Gestational trophoblastic neoplasia (GTN) is a rare tumor that arises from
trophoblastic tissues with high remission rates after chemotherapy treatment. GTN can …

Objective To assess perinatal outcomes of first pregnancy after remission from gestational
trophoblastic neoplasia and the impact of the time between the end of chemotherapy and …

Objective To evaluate the efficacy of immunotherapy for GTN treatment after methotrexate-
resistance or in cases of multiresistant disease, through a systematic review, as well as to …

Objective To investigate the efficacy and toxicity of etoposide, methotrexate, actinomycin D
alternating with cyclophosphamide, and vincristine (EMACO) for treatment of gestational …

Objective To relate preevacuation platelet count and leukogram findings, especially
neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of …